Novel electronic health record-based marker can identify at-risk transplant patients and reduce organ rejection

A new multicenter study led by researchers at the Icahn School of Medicine at Mount Sinai suggests that a novel electronic health record-based marker can help clinicians identify transplant patients at high risk for organ rejection because they are not taking their medications as prescribed—and intervene before the rejection happens.